<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="utf-8">
<meta name="viewport" content="width=device-width,initial-scale=1">
<title>candidate biomarker metabolites is_biomarker_for colorectal cancer — pCite</title>
<link rel="stylesheet" href="../css/style.css">
</head>
<body>
<header>
  <h1><a href="../index.html">pCite</a></h1>
  <nav><a href="../index.html">Search</a><a href="../corpus.html">Corpus</a></nav>
</header>

<p class="section-label">CLAIM</p>
<hr class="section-rule">
<div class="triple">
  <strong>candidate biomarker metabolites</strong>
  <span class="pred">&mdash;is_biomarker_for&rarr;</span>
  <strong>colorectal cancer</strong>
</div>
<div class="entity-id">UNKNOWN:candidate biomarker metabolites &nbsp;&middot;&nbsp; MESH:D015179</div>

<p class="section-label">VALIDATION</p>
<hr class="section-rule">
<div class="val-bar" style="--pct:5%;--color:#f0a030"></div>
<div class="stat-row">
  <span>Class: Curated (0.5)</span>
  <span>Replicated: 1 paper</span>
  <span>Score: 35.35<span class="score-tip"><span class="tip-icon">&nbsp;&#9432;</span><span class="tip-text">Score = &Sigma; incoming citation weights. Each citation is weighted by the validation class of the source claim (Physical 10.0 &middot; Curated 0.5 &middot; AI 0.01) multiplied by the citation type (Replicates 1.5 &middot; Supports 1.0 &middot; Contradicts 0.8). A score of 364 means this claim received strong physical-tier citation support.</span></span></span>
</div>

<p class="section-label">EVIDENCE CHAIN &middot; 1 source</p>
<hr class="section-rule">
<div class="evidence-row"><span class="evidence-dot" style="background:#f0a030" title="Curated"></span><span>Curated</span><a href="https://doi.org/10.1007/s00216-015-8662-x">10.1007/s00216-015-8662-x</a></div>


<p class="section-label">CITATIONS RECEIVED &middot; 43 total</p>
<hr class="section-rule">
<div class="cite-bar"><span style="width:70px;text-align:right">Replicates</span><span class="cite-bar-fill" style="width:0px"></span><span>0</span></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Supports</span><span class="cite-bar-fill" style="width:100px"></span><span>24</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">taurine — decreases → colorectal cancer liver metastasis</span><a href="../claim/085d425052ce8882.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Valine — distinguishes → Colorectal Cancer vs Advanced Adenoma</span><a href="../claim/873f2246ddba4b8e.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">fatty acid metabolites — distinguishes → Hmga1 transgenic mice with polyposis</span><a href="../claim/a87c99a18d869598.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">arginine-enriched tetra-peptide fragments — increases → Hmga1 transgenic mice with polyposis</span><a href="../claim/99363b5c93ff71bb.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">fecal metabolome — distinguishes → colorectal cancer precursor lesions (polyposis)</span><a href="../claim/18e4a43c8b99b01f.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">C16 (palmitoylcarnitine) — distinguishes → Colorectal Cancer vs Colorectal Polyp</span><a href="../claim/097a107cc8d4d0bd.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Arginine — distinguishes → Colorectal Cancer vs Colorectal Polyp</span><a href="../claim/f37b377912e4c09f.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">C4/C8 acylcarnitine ratio — distinguishes → Colorectal Cancer vs Colorectal Polyp</span><a href="../claim/db1a54389dc8484f.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">C5/C3 acylcarnitine ratio — distinguishes → Colorectal Cancer vs Colorectal Polyp</span><a href="../claim/4600209538f68d15.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Phe/Tyr ratio — distinguishes → Colorectal Cancer vs Colorectal Polyp</span><a href="../claim/e608d5ef805f6914.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#ff7f0e"></span><span class="cite-claim-triple">Alanine — distinguishes → Colorectal Cancer vs Colorectal Polyp</span><a href="../claim/92fe9b35055ac855.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">C4/C3 acylcarnitine ratio — distinguishes → Colorectal Cancer vs Colorectal Polyp</span><a href="../claim/28017ee2edd693d6.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">8-metabolite panel (C16, Arg, C4/C8, C5/C3, Val, Phe/Tyr, Ala, C4/C3) — distinguishes → Colorectal Cancer vs Colorectal Polyp</span><a href="../claim/37cf359101a2aad4.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">plasma metabolic profile — distinguishes → metachronous metastasis in stage II colorectal cancer</span><a href="../claim/8c2c7999e9a14ad4.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">plasma metabolic profile — predicts → metachronous metastasis in stage II colorectal cancer</span><a href="../claim/5eb150f836c0cfab.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">plasma metabolic profile — is_biomarker_for → metachronous metastasis in stage II colorectal cancer</span><a href="../claim/649eeb54aa596ed5.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">plasma metabolites — distinguishes → colorectal cancer</span><a href="../claim/25bc564792710f83.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Taurine — distinguishes → colorectal cancer</span><a href="../claim/33e4ff3e124bfc3e.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">5-metabolite panel (endocannabinoid, 2 glycerophospholipids, 2 sphingolipids) — distinguishes → Metastatic Colorectal Cancer vs Healthy Controls</span><a href="../claim/cd40ab420e58928d.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">(-)-Epigallocatechin-3-gallate — inhibits → HT-29 cell proliferation</span><a href="../claim/31766c7322f98355.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">(-)-Epigallocatechin-3-gallate — decreases → differentially expressed genes</span><a href="../claim/238b7e488fac5456.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">(-)-Epigallocatechin-3-gallate — decreases → differentially expressed metabolites</span><a href="../claim/265300925280518e.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">(-)-Epigallocatechin-3-gallate — treats → colorectal cancer</span><a href="../claim/3a88c882e6daeaf5.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">prognosis-related metabolic genes — predicts → Colorectal Cancer</span><a href="../claim/b8892de9cca1d580.html">view &rarr;</a></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Contradicts</span><span class="cite-bar-fill" style="width:8px"></span><span>2</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">(-)-Epigallocatechin-3-gallate — causes → apoptosis</span><a href="../claim/f450cb5afb086188.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">(-)-Epigallocatechin-3-gallate — causes → cell-cycle arrest</span><a href="../claim/81fccc59511669d8.html">view &rarr;</a></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Extends</span><span class="cite-bar-fill" style="width:58px"></span><span>14</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#ff7f0e"></span><span class="cite-claim-triple">taurine — is_biomarker_for → colorectal cancer</span><a href="../claim/c46d79d6a72d684c.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">hypoxanthine — is_biomarker_for → colorectal cancer precursor lesions (polyposis)</span><a href="../claim/7f9ac3cacb789536.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">xanthine — is_biomarker_for → colorectal cancer precursor lesions (polyposis)</span><a href="../claim/9161e9f137fb1277.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">taurine — is_biomarker_for → colorectal cancer precursor lesions (polyposis)</span><a href="../claim/108b69e73c3a3189.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Kynurenine — is_biomarker_for → Colorectal cancer stage</span><a href="../claim/15709a5e8bd22547.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">tryptophan — is_biomarker_for → colorectal cancer</span><a href="../claim/a42864072a5c69c5.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">bile acids — is_biomarker_for → colorectal cancer</span><a href="../claim/4013d9365dfef12a.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">N-oleoylglycine — is_biomarker_for → Metastatic Colorectal Cancer</span><a href="../claim/dd28a089ae91b87a.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">lysophosphatidylcholine (LPC 18:1) — is_biomarker_for → Metastatic Colorectal Cancer</span><a href="../claim/00eed340552f753b.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">lysophosphatidylcholine (LPC 20:3) — is_biomarker_for → Metastatic Colorectal Cancer</span><a href="../claim/aa8d23c580c49512.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">sphingomyelin (SM d18:1/16:0) — is_biomarker_for → Metastatic Colorectal Cancer</span><a href="../claim/54245c9d8ce35c45.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">ceramide (Cer d18:1/24:1) — is_biomarker_for → Metastatic Colorectal Cancer</span><a href="../claim/454fe5cbcb62bb2c.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">TYMS — is_biomarker_for → Colorectal Cancer</span><a href="../claim/40e45e47bda15b0b.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">LDHA — is_biomarker_for → Colorectal Cancer</span><a href="../claim/a461c247774490db.html">view &rarr;</a></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Applies</span><span class="cite-bar-fill" style="width:12px"></span><span>3</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">(-)-Epigallocatechin-3-gallate — causes → autophagy</span><a href="../claim/0f54af221d4f8929.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">(-)-Epigallocatechin-3-gallate — decreases → glutathione metabolism</span><a href="../claim/64499e095d56f314.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">(-)-Epigallocatechin-3-gallate — decreases → glycerophospholipid metabolism</span><a href="../claim/3ead9219d29e702c.html">view &rarr;</a></div>


<p class="section-label">IDENTIFIERS</p>
<hr class="section-rule">
<table class="id-table">
<tr><td>Claim ID</td><td><code>c92a373ef1ba1de6</code></td></tr>
<tr><td>Subject URI</td><td><a href="https://identifiers.org/UNKNOWN:candidate biomarker metabolites">UNKNOWN:candidate biomarker metabolites</a></td></tr>
<tr><td>Object URI</td><td><a href="https://identifiers.org/MESH:D015179">MESH:D015179</a></td></tr>
</table>
<footer>pCite — validation-weighted scientific claims</footer>
</body>
</html>
